150 related articles for article (PubMed ID: 8886295)
1. P300 assessment of opiate and cocaine users: effects of detoxification and buprenorphine treatment.
Kouri EM; Lukas SE; Mendelson JH
Biol Psychiatry; 1996 Oct; 40(7):617-28. PubMed ID: 8886295
[TBL] [Abstract][Full Text] [Related]
2. [Opioid addiction: P300 assessment in treatment by methadone substitution].
Attou A; Figiel C; Timsit-Berthier M
Neurophysiol Clin; 2001 Jun; 31(3):171-80. PubMed ID: 11488228
[TBL] [Abstract][Full Text] [Related]
3. The Leeds Evaluation of Efficacy of Detoxification Study (LEEDS) project: an open-label pragmatic randomised control trial comparing the efficacy of differing therapeutic agents for primary care detoxification from either street heroin or methadone [ISRCTN07752728].
Oldham NS; Wright NM; Adams CE; Sheard L; Tompkins CN
BMC Fam Pract; 2004 Apr; 5():9. PubMed ID: 15117415
[TBL] [Abstract][Full Text] [Related]
4. Event-related potential changes in cocaine withdrawal: evidence for long-term cognitive effects.
Noldy NE; Carlen PL
Neuropsychobiology; 1997; 36(1):53-6. PubMed ID: 9211446
[TBL] [Abstract][Full Text] [Related]
5. Comparison of efficacy between buprenorphine and tramadol in the detoxification of opioid (heroin)-dependent subjects.
Chawla JM; Pal H; Lal R; Jain R; Schooler N; Balhara YP
J Opioid Manag; 2013; 9(1):35-41. PubMed ID: 23709302
[TBL] [Abstract][Full Text] [Related]
6. Desipramine in opioid-dependent cocaine abusers maintained on buprenorphine vs methadone.
Oliveto AH; Feingold A; Schottenfeld R; Jatlow P; Kosten TR
Arch Gen Psychiatry; 1999 Sep; 56(9):812-20. PubMed ID: 12884887
[TBL] [Abstract][Full Text] [Related]
7. Responsiveness to drug cues and natural rewards in opiate addiction: associations with later heroin use.
Lubman DI; Yücel M; Kettle JW; Scaffidi A; Mackenzie T; Simmons JG; Allen NB
Arch Gen Psychiatry; 2009 Feb; 66(2):205-12. PubMed ID: 19188543
[TBL] [Abstract][Full Text] [Related]
8. Using buprenorphine to facilitate entry into residential therapeutic community rehabilitation.
Collins ED; Horton T; Reinke K; Amass L; Nunes EV
J Subst Abuse Treat; 2007 Mar; 32(2):167-75. PubMed ID: 17306725
[TBL] [Abstract][Full Text] [Related]
9. Buprenorphine/naloxone versus methadone and lofexidine in community stabilisation and detoxification: A randomised controlled trial of low dose short-term opiate-dependent individuals.
Law FD; Diaper AM; Melichar JK; Coulton S; Nutt DJ; Myles JS
J Psychopharmacol; 2017 Aug; 31(8):1046-1055. PubMed ID: 28631527
[TBL] [Abstract][Full Text] [Related]
10. Anesthesia-assisted vs buprenorphine- or clonidine-assisted heroin detoxification and naltrexone induction: a randomized trial.
Collins ED; Kleber HD; Whittington RA; Heitler NE
JAMA; 2005 Aug; 294(8):903-13. PubMed ID: 16118380
[TBL] [Abstract][Full Text] [Related]
11. Heroin detoxification with buprenorphine on an inpatient psychiatric unit.
DiPaula BA; Schwartz R; Montoya ID; Barrett D; Tang C
J Subst Abuse Treat; 2002 Oct; 23(3):163-9. PubMed ID: 12392802
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of a transdermal buprenorphine formulation in opioid detoxification.
Lanier RK; Umbricht A; Harrison JA; Nuwayser ES; Bigelow GE
Addiction; 2007 Oct; 102(10):1648-56. PubMed ID: 17854341
[TBL] [Abstract][Full Text] [Related]
13. Rapid detoxification of heroin dependence by buprenorphine.
Liu ZM; Cai ZJ; Wang XP; Ge Y; Li CM
Zhongguo Yao Li Xue Bao; 1997 Mar; 18(2):112-4. PubMed ID: 10072959
[TBL] [Abstract][Full Text] [Related]
14. Comparison of pharmacological treatments for opioid-dependent adolescents: a randomized controlled trial.
Marsch LA; Bickel WK; Badger GJ; Stothart ME; Quesnel KJ; Stanger C; Brooklyn J
Arch Gen Psychiatry; 2005 Oct; 62(10):1157-64. PubMed ID: 16203961
[TBL] [Abstract][Full Text] [Related]
15. Heroin detoxification with a single high dose of buprenorphine.
Kutz I; Reznik V
Isr J Psychiatry Relat Sci; 2002; 39(2):113-9. PubMed ID: 12227226
[TBL] [Abstract][Full Text] [Related]
16. Emergency management of inadvertent accelerated opiate withdrawal in dependent opiate users.
Lubman D; Koutsogiannis Z; Kronborg I
Drug Alcohol Rev; 2003 Dec; 22(4):433-6. PubMed ID: 14660133
[TBL] [Abstract][Full Text] [Related]
17. Bringing buprenorphine-naloxone detoxification to community treatment providers: the NIDA Clinical Trials Network field experience.
Amass L; Ling W; Freese TE; Reiber C; Annon JJ; Cohen AJ; McCarty D; Reid MS; Brown LS; Clark C; Ziedonis DM; Krejci J; Stine S; Winhusen T; Brigham G; Babcock D; Muir JA; Buchan BJ; Horton T
Am J Addict; 2004; 13 Suppl 1(Suppl 1):S42-66. PubMed ID: 15204675
[TBL] [Abstract][Full Text] [Related]
18. Short-term outcomes after brief ambulatory opioid detoxification with buprenorphine in young heroin users.
Gandhi DH; Jaffe JH; McNary S; Kavanagh GJ; Hayes M; Currens M
Addiction; 2003 Apr; 98(4):453-62. PubMed ID: 12653815
[TBL] [Abstract][Full Text] [Related]
19. Electrophysiological evidence of the motivational salience of drug cues in opiate addiction.
Lubman DI; Allen NB; Peters LA; Deakin JF
Psychol Med; 2007 Aug; 37(8):1203-9. PubMed ID: 17274853
[TBL] [Abstract][Full Text] [Related]
20. Ultra-rapid opiate detoxification using deep sedation and prior oral buprenorphine preparation: long-term results.
Bochud Tornay C; Favrat B; Monnat M; Daeppen JB; Schnyder C; Bertschy G; Besson J
Drug Alcohol Depend; 2003 Apr; 69(3):283-8. PubMed ID: 12633914
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
